Literature DB >> 3713446

Separation of underivatized gangliosides by ion exchange high performance liquid chromatography.

M M Whalen, G C Wild, W D Spall, R J Sebring.   

Abstract

A procedure is described which separates neutral glycolipids from gangliosides, and which separates the gangliosides into classes, based on their number of sialic acid residues. In addition to separation into mono-, di- and trisialoganglioside classes, there is purification of individual disialoganglioside species. The procedure uses a commercially available--NH2 high performance liquid chromatography (HPLC) column, which normally is used as an adsorption column. In this method the column is modified by protonation, to pH 5.4, so that it exhibits ion exchange as well as adsorption properties. Sensitive, nondestructive detection of eluent peaks is accomplished by monitoring continuously at 210 nm, a wavelength near which underivatized glycosphingolipids have absorbance maxima and which also will clearly detect most possible contaminants. An entire run, including re-equilibration of the column, takes two hours.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713446     DOI: 10.1007/bf02536409

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

Review 1.  THE GANGLIOSIDES.

Authors:  L SVENNERHOLM
Journal:  J Lipid Res       Date:  1964-04       Impact factor: 5.922

2.  High-pressure liquid chromatography of glycosphingolipids (with special reference to gangliosides).

Authors:  U R Tjaden; J H Krol; R P Van Hoeven; E P Oomen-Meulemans; P Emmelot
Journal:  J Chromatogr       Date:  1977-06-11

3.  An improved method of microdialysis.

Authors:  C K Lau; J M Fujitaki
Journal:  Anal Biochem       Date:  1981-01-01       Impact factor: 3.365

4.  Carbohydrate composition of normal and variant human alpha 1-protease inhibitors.

Authors:  A Yoshida; T Mega
Journal:  Arch Biochem Biophys       Date:  1979-07       Impact factor: 4.013

5.  A rapid and quantitative method for the isolation of gangliosides and neutral glycosphingolipids by DEAE-silica gel chromatography.

Authors:  S K Kundu; S K Roy
Journal:  J Lipid Res       Date:  1978-03       Impact factor: 5.922

6.  A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1.

Authors:  R Kannagi; E Nudelman; S B Levery; S Hakomori
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

7.  Rapid separation of gangliosides by high-performance liquid chromatography.

Authors:  S K Kundu; D D Scott
Journal:  J Chromatogr       Date:  1982-10-08

8.  High resolution preparative column chromatographic system for gangliosides using DEAE-Sephadex and a new porus silica, Iatrobeads.

Authors:  T Momoi; S Ando; Y Magai
Journal:  Biochim Biophys Acta       Date:  1976-09-27

9.  Gangliosides of human, cat, and rabbit spinal cords and cord myelin.

Authors:  K Ueno; S Ando; R K Yu
Journal:  J Lipid Res       Date:  1978-09       Impact factor: 5.922

10.  A new solvent system for the separation of neutral glycosphingolipids.

Authors:  K Watanabe; Y Arao
Journal:  J Lipid Res       Date:  1981-08       Impact factor: 5.922

View more
  3 in total

1.  Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs.

Authors:  Udayanath Aich; M Adam Meledeo; Srinivasa-Gopalan Sampathkumar; Jie Fu; Mark B Jones; Christopher A Weier; Sung Yun Chung; Benjamin C Tang; Ming Yang; Justin Hanes; Kevin J Yarema
Journal:  Glycoconj J       Date:  2010-05-11       Impact factor: 2.916

Review 2.  Sphingolipidomics: methods for the comprehensive analysis of sphingolipids.

Authors:  Christopher A Haynes; Jeremy C Allegood; Hyejung Park; M Cameron Sullards
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-12-31       Impact factor: 3.205

3.  The major gangliosides of the bovine pineal body.

Authors:  M M Whalen; G C Wild
Journal:  Lipids       Date:  1987-01       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.